Outpatient Surgery Magazine

Say Yes to Total Hips - March 2014 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/273913

Contents of this Issue

Navigation

Page 62 of 146

5 Days 4 Days 3 Days 2 Days 1 Day 12 hours EXPAREL ® (bupivacaine liposome injectable suspension) is promoted as providing pain control that lasts for up to 72 hours without the need for catheters and pumps. 1 In fact, their two pivotal studies tell a different story. 2-4 We feel it is important that you know the facts. A K I M B E R L Y - C L A R K H E A L T H C A R E C O M P A N Y FACT VS FICTION Every day without costs you more 5 Every day without • Using limited studies and cumulative data, EXPAREL ® claims that a single injection can provide up to three days of "patient-focused pain control." 1 Yet, in a pivotal bunionectomy study, it is no more effective than a placebo beyond 12 hours. 3 • EXPAREL ® is not titratable. 5 – Cannot control fl ow rate – Cannot turn on or off as needed • In a pivotal study, after 12 hours there was no attendant decrease in morphine consumption. 4 ON-Q* has demonstrated effectiveness across multiple procedures in over 150 studies. We have provided over 3.5 million patients with effective, safe, personalized pain relief for up to fi ve days, not just 24 hours. 6 ON-Q* Proven. Controllable. Long-lasting. 6 Contact your ON-Q* representative for more information. EXPAREL's studies only demonstrate 12 hours of pain relief. 3-4 1 EXPAREL ® . Advertisement. Outpatient Surgery 1 Nov. 2013: 57-58. Print. Outpatient Surgery 2 EXPAREL ® [prescribing information]. Parsippany, NJ: Pacira Pharmaceuticals, Inc.; 2011. 3 Golf M, Daniels SE, Onel E. A Phase III, randomized, placebo controlled trial of DepoFoam ® bupivacaine (extended-re- lease bupivacaine local analgesic) in bunionectomy. Adv Ther. Sep 2011;28(9):776-788. 4 Gorfi ne SR, Onel E, Patou G, et al. Bupivacaine Extended-Release Liposome Injection for Prolonged Postsurgical Analgesia in Patients Undergoing Hemorrhoidectomy: A Multicenter,Randomized, Double-blind, Placebo-controlled Trial. Dis Colon Rectum. Dec 2011;54(12):1552-1159. 5 Ilfeld B, Liposome bupivacaine in peripheral nerve blocks and epidural injections to manage postoperative pain. Expert Opin. Pharmacther. (2013) 14(17):2421-2431. 6 Data on fi le. I-Flow* LLC A Kimberly-Clark Healthcare Company. 43 Discovery, Suite 100 Irvine CA, 92618 USA. ON-Q* Pain Relief System *Registered trademark or trademark of Kimberly-Clark Worldwide Inc. © 2014 KCWW All rights reserved. RX Only. MK-00637 2/2014. OSE_1403_part2_Layout 1 3/5/14 10:52 AM Page 63

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Say Yes to Total Hips - March 2014 - Subscribe to Outpatient Surgery Magazine